Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ON Semiconductor (ON) vs ResMed Inc. (RMD) Price & Performance

ON SemiconductorTrade
ResMed Inc.Trade

Price performance (Past 24H)

Key statistics

ON Semiconductor vs ResMed Inc. — how do they compare? ON Semiconductor trades at $80.64 (market cap $30.92B), while ResMed Inc. trades at $225.92 (market cap $31.89B). The key difference: ON Semiconductor and ResMed Inc. are close in size by market cap, and ResMed Inc. pays a 1.16% dividend while ON Semiconductor pays none. Which is the better fit depends on your goals — on Pluang, investors hold ON Semiconductor for 5 Days and ResMed Inc. for 51 Days on average.

ONRMD
Market Cap
$30.92B$31.89B
Volume
11,639,037618,314
Sector
TechnologyHealth
52-Week High
$133.93$277.88
52-Week Low
$44.90$182.82
Typical Hold Time
5 Days51 Days
Enterprise Value
$31.53B$31.24B
Dividend Yield
—1.16%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ON Semiconductor

No Aura AI signal available yet.

ResMed Inc.

ResMed (RMD) trades at $225.98, up 2.4% today, with a bullish technical signal and strong fundamentals. Revenue grew to $5.15B in 2025, with net income at $1.40B and a 26.94% net margin. Recent earnings beats and a 12-14% EPS growth outlook support momentum. The stock is near its pivot point of $227, with support at $225 and resistance at $228.

Outlook is positive with analyst consensus at Buy and a $242.70 price target. Risks include competitive pressures and ongoing legal investigations. Institutional buying and solid cash flow growth underpin the bullish case, though macroeconomic and regulatory factors warrant monitoring.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ON
75% Buy25% Sell
Avg holding period · 5 Days
RMD
80% Buy20% Sell
Avg holding period · 51 Days

Top news

Latest headlines on both assets

About ON Semiconductor

Onsemi develops power and sensing semiconductors for automotive, industrial, and energy applications. Its products support functions such as electric vehicle systems, energy conversion, automation, and intelligent sensing.

Read more on ON →

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Read more on RMD →